Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-18

Clinical Trial Update: Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects [Phase 4]

View source ↗

Summary

Phase 4 efficacy trial comparing liraglutide, sitagliptin, and insulin glargine for liver fat in adults with type 2 diabetes mellitus and non-alcoholic fatty li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Sitagliptin (sitagliptin)
  • liraglutide (liraglutide)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-alcoholic Fatty Liver Disease | Phase 4 | Status: COMPLETED